This distributed inhibition is predicted to overcome compensatory pathway activation that limits anti-TNF and JAK inhibitor monotherapies, positioning these polyphenols as rational leads for next-generation, multi-target disease-modifying strategies in rheumatoid arthritis. Here, TNF is linked to rheumatoid arthritis.